Ron Wyden

I am going to ask you a question that I would like a response on in writing within a week because this is so important to me.

I think this is an important hearing, and Senator Cantwell has already picked up on a couple of our key issues in the Pacific Northwest.

I do not see how growth is going to get you close to paying for that $1.9 trillion that was put on the credit card.

So you cannot just wave your hands and sort of throw up fairy dust and say you are going to drive down the debt.

I do not know where else Republicans could possibly go to pay for this $1.9 trillion in debt largely going to the multinational corporations.

Our approach would have put the bulk of the tax relief into the pockets of the middle class rather than the multinational corporations.

I think based on your answer I have to tell Oregonians that it is going to take more than 10 years.

This issue of auditing the Pentagon is the longest running battle since the Trojan War.

Everybody else in Government gets audited. Businesses get audited. It really is the longest running battle since the Trojan War.

I am going to take that as a yes, that it is going to take more than 10 years to get to a clean audit.

I support both of these nominees this morning, Mr. Chairman.

If there is a plan to deal with China's trade practices, this committee and the American people want to know what it is.

It's long been my view that NAFTA should be completely overhauled.

This administration, including the Office of the U.S. Trade Representative, has fallen short on transparency and consultations with Congress, stakeholders and the public.

Millions of Americans are employed in the service sector in fields like science and technology, which accounted for about a third of U.S. exports.

I am very favorably inclined towards your candidacy here, your nomination.

Transparency goes right to the heart of what I think a smart trade policy is.

What we ought to be concerned about is if there's a secret interpretation that's different than what people read.

If an intelligence operation is inconsistent with the public's understanding of the law, that is a prescription for trouble.

To say this administration hasn't yet delivered would be a wild understatement.

The same Donald Trump who said almost exactly one year ago that price-hiking drug companies were 'getting away with murder' has nominated a drug company executive.

That is not the question. Did you ever lower the price? That is the question I----

Let the record show that when that specific question for Mr. Azar was asked--did he ever lower the price of a Lilly drug sold in the United States, Mr. Azar said 'no.'

I would like the measure of success to be finding jobs for people so you can get out of poverty.

No amount of flexibility is going to compensate for those types of cuts.